Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26206
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBukach, O.-
dc.contributor.authorAriichuk, D.-
dc.contributor.authorBabchenko, V.-
dc.contributor.authorSoha, N.-
dc.contributor.authorStefurak, M.-
dc.date.accessioned2025-02-21T07:46:53Z-
dc.date.available2025-02-21T07:46:53Z-
dc.date.issued2024-
dc.identifier.otherDOI: 10.5281/zenodo.11624463-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26206-
dc.description.abstractAbstract. Systemic lupus erythematosus (SLE) is one of the most serious systemic connective tissue diseases that develops more often in young women and girls, although it can occur at any age. Patients with SLE still have a high risk of death (3 times higher than in the general population). Early diagnosis, intensification of basic therapy and minimization of the dose of glucocorticoids (GC), assessment of cardiovascular risk and treatment of cardiovascular diseases are considered to be the basis for improving the prognosis in SLE.uk_UA
dc.language.isoenuk_UA
dc.publisherSlovak international scientific journaluk_UA
dc.subjectsystemic lupus erythematosusuk_UA
dc.subjectfacial erythemauk_UA
dc.subjectpolyarthritisuk_UA
dc.subjectpneumosclerosisuk_UA
dc.subjectmyocardiofibrosisuk_UA
dc.titleA clinical case in the practice of a rheumatologist: systemic lupus erythomus with inflammation of organs and systemsuk_UA
dc.typeArticleuk_UA
Appears in Collections:Статті

Files in This Item:
File Description SizeFormat 
Bukach O. et al. A clinical_63-65_2024.pdf117.38 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.